Exact Sciences Corp. (NASDAQ: EXAS) flaunted slowness of -0.01% at $70.26, before settling in for the price of $70.27 at the close. Taking a more long-term approach, EXAS posted a 52-week range of $40.62-$79.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 43.88%. Meanwhile, its Annual Earning per share during the time was 4.59%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 17.60%. This publicly-traded company’s shares outstanding now amounts to $184.77 million, simultaneously with a float of $181.98 million. The organization now has a market capitalization sitting at $12.98 billion. At the time of writing, stock’s 50-day Moving Average stood at $65.50, while the 200-day Moving Average is $58.79.
Exact Sciences Corp. (EXAS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Exact Sciences Corp. industry. Exact Sciences Corp.’s current insider ownership accounts for 1.51%, in contrast to 97.37% institutional ownership. According to the most recent insider trade that took place on Oct 08 ’24, this organization’s EVP, GM, Precision Oncology sold 929 shares at the rate of 70.00, making the entire transaction reach 65,030 in total value, affecting insider ownership by 12,758.
Exact Sciences Corp. (EXAS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
Exact Sciences Corp.’s EPS increase for this current 12-month fiscal period is 17.60% and is forecasted to reach 0.15 in the upcoming year.
Exact Sciences Corp. (NASDAQ: EXAS) Trading Performance Indicators
Let’s observe the current performance indicators for Exact Sciences Corp. (EXAS). It’s Quick Ratio in the last reported quarter now stands at 1.98. The Stock has managed to achieve an average true range (ATR) of 2.35. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.97.
In the same vein, EXAS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.96, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be 0.15 at the market close of one year from today.
Technical Analysis of Exact Sciences Corp. (EXAS)
Now, what If we examine the latest scores posted by [Exact Sciences Corp., EXAS]. During the last 5-days, its volume was lower the volume of 2.56 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 59.35% While, its Average True Range was 2.27.
Raw Stochastic average of Exact Sciences Corp. (EXAS) in the period of the previous 100 days is set at 94.48%, which indicates a major rise in contrast to 65.07% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 28.38% that was lower than 57.55% volatility it exhibited in the past 100-days period.
